About CBM Lifemotion®
Innovation for Life-Support Technologies.
Our Mission
Advancing Access to Critical Care
At CBM, we design ECMO technology with a focus on precision, portability, and reliability — helping healthcare teams expand access to advanced life support in approved markets. By combining engineering innovation with collaboration, we aim to support high‑quality care in diverse clinical settings worldwide.
Our Commitment
Innovating together to advance lifesaving care
We collaborate with governments, hospitals, healthcare providers, and families to help address critical gaps in care. By combining partnerships with proven medical technology, we aim to contribute to more resilient and inclusive healthcare systems for the future.
Our Purpose
Saving lives with compassion and precision
Every innovation we create is guided by a single mission: to protect life. Whether in the ICU or during emergency transport, our ECMO technology is designed to deliver when seconds count—empowering care teams and improving outcomes everywhere it’s needed.
Our Vision
A Future Where No Life is Lost Due to Lack
of Advanced Care
A future where advanced care is within reach for all who need it
We envision a world where healthcare innovation has no boundaries — where medical technology continues to advance to support critical care in diverse settings.
Our goal is to contribute to making ECMO solutions more accessible and innovative, so more patients, regardless of location, can benefit from timely, high‑quality life support. Together, we aim to inspire positive change in critical care across continents.
- Every life deserves a second chance.
- Turning the tide in global healthcare.
Our Story
Transforming ECMO Technology
for a Better Future
Advancing ECMO Technology for a Better Future
for a Better Future
In 2016, our team identified a significant opportunity to improve ECMO (Extracorporeal Membrane Oxygenation) technology. While its clinical applications had expanded over the previous decades, much of the available equipment had not evolved to fully meet emerging needs.
To address this, we assembled a global network of engineers and medical professionals to apply advanced industrial technology to ECMO system development. By focusing on key clinical challenges, we have introduced solutions designed to support effective treatment and broaden access to ECMO in modern healthcare settings.
Today, we continue to drive innovation in ECMO design, equipping healthcare providers with technology that supports high‑quality critical care.
Lifemotion® ECMO is now approved by leading regulatory bodies across Europe, Latin America, Africa, and Asia — including CE Mark (EU), ISP (Chile), SAHPRA (South Africa), MDD (Hong Kong), and MHRA (UK). Delivering safe, reliable, and advanced care for critically ill patients worldwide.
